The Society of Interventional Radiology (SIR) announced that the CAPTAIN randomized clinical trial found that men with ...

Please provide your email address to receive an email when new articles are posted on . Benign prostatic hyperplasia is the most common benign tumor found in men. Prostate artery embolization is ...

A new randomized clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster and experienced less short‑term impact on their daily lives when treated with ...

COLUMBUS, Ohio--(BUSINESS WIRE)--Central Ohio Urology Group has opened a state-of-the-art Interventional Radiology Center and launched a groundbreaking initiative in the treatment of benign prostatic ...

FAIRFAX, Va. (March 20, 2024)—A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation is effective in treating prostate cancer, according to new research ...

INDIANAPOLIS--(BUSINESS WIRE)--Urology of Indiana is now offering a groundbreaking initiative in the treatment of benign prostatic hyperplasia (BPH) or enlarged prostate, including the opening of a ...

A joystick-like robot lets Emory doctors guide a tiny wire to blocked blood vessels, offering precise, minimally invasive ...

Laguna Hills, Calif.-based Orange County Urology Associates has partnered with IR Centers and Prostate Centers USA to develop an outpatient interventional radiology program.  The program will ...

Vascular and Interventional Radiology (VIR) is a sub-specialty of Diagnostic Radiology that has rapidly evolved over the past 30 years to become an integral part of comprehensive patient care, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Dr. Ravindran Ramalingam is a leading Interventional Radiologist in Chennai, specializing in advanced endovascular and ...

TORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, ...